Skip to main content
Premium Trial:

Request an Annual Quote

Rutgers Cancer Institute Lands Donation for Pediatric Cancer Profiling Trial

NEW YORK (GenomeWeb News) – The Rutgers Cancer Institute of New Jersey has received a $300,000 donation from the Hugs for Brady Foundation to fund a personalized pediatric cancer treatment research program, Rutgers University said today.

Rutgers said the foundation awarded the funds in order to fill "a need to further explore genomic profiling in pediatric malignancies," as many of the cancer therapies that have been targeted toward specific cancer mutations have been studies only in adult patients.

Investigators at the institute currently are engaged in a genomic analysis trial that is focused on patients with rare or poor-prognosis cancers, and which includes pediatric patients.

Rutgers said a team that includes physician-scientists, bioinformaticians, systems biologists, pathologists, and others meets weekly to discuss patients' profiling results and to determine their therapeutic options.

The trial is led by Shridar Ganesan, associate director for translational science and director of the institute's Functional Genomics Shared Resource, which houses a range of genomics capabilities and services, including genome sequencing, gene expression analysis and profiling, and others.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.